O
OrbiMed
Private Equity · Founded 1989 · New York City, United States
OrbiMed’s biggest current holdings.
The most valuable companies OrbiMed still holds — unicorns and thoroughbreds it has backed, ordered by Dealroom’s latest valuation. Companies that have been acquired or gone public are in Exits instead. Where a cap table names OrbiMed directly, the stake and its estimated value are shown too.
-
1
Miaoshou Doctor
0.7%
$2.3B
$16M
-
2
Treeline Biosciences
—
$2.1B
—
-
3
Verdiva Bio
—
$2.0B
—
-
4
vVardis
—
$1.0B
—
-
5
PharmEasy
—
$710M
—
Estimated value = OrbiMed’s disclosed ownership % × Dealroom’s latest company valuation; direct named stakes only, exited positions excluded. Figures are indicative, not reported marks. See the underlying cap tables on Dealroom →
OrbiMed’s biggest exits.
Portfolio companies that IPO’d or were acquired at $1B+, with the valuation recorded at exit and — for those still public — their value today. Exit events come from each company’s funding-round history; entry stage from OrbiMed’s transaction record.
Where OrbiMed’s portfolio is concentrated.
Distribution of portfolio companies by headquarters country, sector, entry stage and current growth stage. Across all 393 portfolio companies. "Stage entered" is the first priced round the investor joined, derived from the investor’s transaction history.
-
USA309
-
China54
-
Israel26
-
India17
-
UK15
-
Canada11
-
Switzerland8
-
France6
-
Denmark4
-
Germany4
-
Hong Kong4
-
Ireland4
-
Health438
-
Wellness Beauty8
-
Enterprise Software7
-
Sports3
-
Jobs Recruitment2
-
Kids2
-
Marketing2
-
Security2
-
Energy1
-
Fintech1
-
Food1
-
Media1
-
Series B+226
-
Series A138
-
Seed12
-
Late Growth298
-
Breakout Stage139
-
Early Growth32
-
Mature4
Inside OrbiMed’s portfolio.
The 60 highest-funded portfolio companies, of 393 tracked.
Ph
CaTrMi
Za
Be
I-
Od
Xt
Av
Mi
Ab
Ce
AC
Gu
In
Di
Ol
In
Ar
Cr
Sp
Ga
Sc
Ra
CoVe
Ad
Up
Ar
Cu
Ac
Ca
An
Al
Wi
Te
Ty
Pi
Re
As
Er
Sh
Ca
Cl
De
Ad
Ik
AD
Ha
Re
So
St
Ar
Ge
Ha
Ha
Na
Ia
AmWhere OrbiMed’s portfolio founders come from.
139 founders across the 100 highest-funded portfolio companies — by current location, university attended, and the companies they worked at before founding. Sourced from the founder records the API links to each portfolio company.
-
United States93
-
China12
-
Denmark6
-
Canada4
-
Israel4
-
Australia3
-
India3
-
Netherlands3
-
United Kingdom3
-
Germany2
-
Harvard University11
-
Massachusetts Institute of Technology8
-
Stanford University5
-
University of California, Berkeley4
-
Wharton School of the University of Pennsylvania4
-
Columbia University3
-
Harvard Medical School3
-
University of Copenhagen3
-
University of Texas at Austin3
-
University of Virginia3
-
Novartis6
-
Alantos Pharmaceuticals5
-
Genentech5
-
Massachusetts Institute of Technology5
-
McKinsey & Company5
-
Sanofi Aventis5
-
Harvard Medical School3
-
Lucentis3
-
MIT-IBM Watson AI Lab3
-
Aiolos Bio2
Similar investors.
Peers the API surfaces as most similar by portfolio shape, with Dealroom investor rank and portfolio scale.
Key people at OrbiMed.
